
Spotlight on Spinocerebellar Ataxia 7: Unraveling the Genetic Threads
An ATXN7 mutation produces an abnormal protein that builds up in the brain, causing loss of coordination and retinal degeneration; DNA analysis detects it.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

An ATXN7 mutation produces an abnormal protein that builds up in the brain, causing loss of coordination and retinal degeneration; DNA analysis detects it.

Gait instability, slurred speech and seizures can occur together in SCA-E, usually beginning in adulthood; testing separates it from other ataxias and epilepsies.

Which mutation a thyroid carcinoma carries shapes monitoring and targeted treatment. Familial risk and reported carotid body tumor cases are also described.

An abnormal link between cerebral arteries and the deep venous system can bring cardiac failure and hydrocephalus in infants; MRI and CT assess the malformation.

Bleeding severity varies widely in VWD2A, even between relatives carrying the same VWF variant, because the factor is produced but does not work properly.

Enhanced platelet agglutination and a low platelet count set type 2B apart; when the ristocetin assay is ambiguous, VWF gene analysis gives a clearer answer.

In VWD 2M the A1 domain of VWF is altered, as in the Milwaukee-1 in-frame deletion, so the factor binds platelets poorly and desmopressin response may differ.

Also called the Normandy variant, this autosomal recessive form stops Factor VIII binding to vWF, producing bleeding that resembles mild Hemophilia A.